Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

CTX

Crescita Therapeutics (CTX)

Crescita Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:CTX
DateTimeSourceHeadlineSymbolCompany
06/01/20235:00AMPR Newswire (Canada)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
06/01/20235:00AMPR Newswire (US)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
06/01/20235:00AMPR Newswire (US)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
01/21/20217:30AMPR Newswire (US)Crescita Announces Filing of New Medical Device LicenseTSX:CTXCrescita Therapeutics Inc
01/21/20217:30AMPR Newswire (Canada)Crescita Announces Filing of New Medical Device LicenseTSX:CTXCrescita Therapeutics Inc
11/26/20207:30AMPR Newswire (Canada)Crescita Therapeutics Announces Approval of Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
11/26/20207:30AMPR Newswire (US)Crescita Therapeutics Announces Approval of Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
11/12/20207:30AMPR Newswire (Canada)Crescita Reports Third Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
11/12/20207:30AMPR Newswire (US)Crescita Reports Third Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
11/05/20207:30AMPR Newswire (Canada)Crescita Announces Licensing Agreement for Pliaglis® in ChinaTSX:CTXCrescita Therapeutics Inc
11/05/20207:30AMPR Newswire (US)Crescita Announces Licensing Agreement for Pliaglis® in ChinaTSX:CTXCrescita Therapeutics Inc
08/12/20207:30AMPR Newswire (US)Crescita Reports Second Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
08/12/20207:30AMPR Newswire (Canada)Crescita Reports Second Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
07/28/20207:30AMPR Newswire (US)Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing AgreementTSX:CTXCrescita Therapeutics Inc
07/28/20207:30AMPR Newswire (Canada)Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing AgreementTSX:CTXCrescita Therapeutics Inc
05/27/20207:30AMPR Newswire (US)Crescita Reports First Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
05/27/20207:30AMPR Newswire (Canada)Crescita Reports First Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
05/14/20208:30AMPR Newswire (US)Crescita Therapeutics Announces the Results of its Annual General Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
05/14/20208:30AMPR Newswire (Canada)Crescita Therapeutics Announces the Results of its Annual General Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
04/28/20205:58PMPR Newswire (US)Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19TSX:CTXCrescita Therapeutics Inc
04/28/20205:58PMPR Newswire (Canada)Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19TSX:CTXCrescita Therapeutics Inc
03/24/20207:23PMPR Newswire (US)Crescita Therapeutics Announces Measures in Response to COVID-19 VirusTSX:CTXCrescita Therapeutics Inc
03/24/20207:23PMPR Newswire (Canada)Crescita Therapeutics Announces Measures in Response to COVID-19 VirusTSX:CTXCrescita Therapeutics Inc
03/18/20207:30AMPR Newswire (US)Crescita Reports Q4 and Fiscal 2019 ResultsTSX:CTXCrescita Therapeutics Inc
03/18/20207:30AMPR Newswire (Canada)Crescita Reports Q4 and Fiscal 2019 ResultsTSX:CTXCrescita Therapeutics Inc
03/10/20209:30AMPR Newswire (Canada)Pliaglis® finally available in CanadaTSX:CTXCrescita Therapeutics Inc
03/10/20209:30AMPR Newswire (Canada)Pliaglis® enfin disponible au CanadaTSX:CTXCrescita Therapeutics Inc
02/11/20207:30AMPR Newswire (US)Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...TSX:CTXCrescita Therapeutics Inc
02/11/20207:30AMPR Newswire (Canada)Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...TSX:CTXCrescita Therapeutics Inc
01/24/20207:30AMPR Newswire (US)Crescita Awarded Cannabis Research License from Health CanadaTSX:CTXCrescita Therapeutics Inc
 Showing the most relevant articles for your search:TSX:CTX